{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:03:37Z","timestamp":1786993417156,"version":"build-2736575974"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Cancer Association of South Africa (CANSA)"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jsbmb.2017.07.022","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T22:16:22Z","timestamp":1500761782000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-\u03b1 and -\u03b2"],"prefix":"10.1016","volume":"174","author":[{"given":"Meghan S.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Louw-du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita","family":"Africander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2017.07.022_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0025-7125(05)70608-8","article-title":"Menopause and hormone replacement therapy","volume":"82","author":"Johnson","year":"1998","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","article-title":"The menopause","volume":"353","author":"Greendale","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0960-0760(02)00258-3","article-title":"The menopause, hormone replacement therapy and breast cancer","volume":"83","author":"Marsden","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0020","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ejca.2008.07.041","article-title":"Hormone replacement therapy and the risk of breast cancer","volume":"44","author":"Cuzick","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsbmb.2013.11.011","article-title":"Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe?","volume":"142","author":"Stanczyk","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0030","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mob.2002.122852","article-title":"Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs","volume":"187","author":"Riis","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0035","first-page":"79","article-title":"A clinical evaluation of ethinyl estradiol in the menopause","volume":"5","author":"Dubrow","year":"1950","journal-title":"N. Y. State J. Med."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","article-title":"Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action","volume":"142","author":"Bhavnani","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jech.2005.033316","article-title":"Hormone replacement therapy, cancer, controversies, and women\u2019s health: historical, epidemiological, biological, clinical, and advocacy perspectives","volume":"59","author":"Krieger","year":"2005","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0050","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6874-7-2","article-title":"The Women\u2019s international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial","volume":"7","author":"Vickers","year":"2007","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s Health Initiaitive Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"M.W.S. Collaborators, Million Women Study Collaborators","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0070","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0075","series-title":"Cochrane Database Systematic Reviews","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2017"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/jc.2011-2492","article-title":"Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy","volume":"97","author":"Bhavnani","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0085","first-page":"332","article-title":"Natural hormone replacement therapy: what it is and what consumers really want","volume":"5","author":"Reed-Kane","year":"2001","journal-title":"Int. J. Pharm. Compd."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0090","first-page":"163","article-title":"Bioidentical hormones for menopausal therapy","volume":"4","author":"Sites","year":"2008","journal-title":"Womens Health"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2009.08.002","article-title":"Bioidentical hormones for maturing women","volume":"64","author":"Chervenak","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003081-200112000-00024","article-title":"Unconventional estrogens: estriol, biest, and triest","volume":"44","author":"Taylor","year":"2001","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0105","series-title":"Jaffe\u2019s Reprod. Endocrinol. Seventh Ed. Physiol. Pathophysiol. Clin. Manag.","first-page":"66","article-title":"The synthesis and metabolism of steroid hormones","author":"Strauss","year":"2014"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sram.2005.09.003","article-title":"Bioidentical estrogens: hope or hype?","volume":"3","author":"Taylor","year":"2005","journal-title":"Sex. Reprod. Menopause"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/jwh.2006.0311","article-title":"Bioidentical hormone therapy: a review of the evidence","volume":"16","author":"Cirigliano","year":"2007","journal-title":"J. Womens Health"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.GME.0000094356.92081.EF","article-title":"Bioidentical hormone therapy: a review","volume":"11","author":"Boothby","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0125","series-title":"Bio-Identicals. Sorting Myths from Facts","year":"2008"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurpra.2009.03.011","article-title":"Bioidentical hormones, compounding, and evidence- based medicine: what women\u2019s health practitioners need to know","volume":"5","author":"Bosarge","year":"2009","journal-title":"J. Nurse Pract."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0135","first-page":"208","article-title":"A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks","volume":"11","author":"Moskowitz","year":"2006","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0140","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1210\/mend.11.12.0025","article-title":"Molecular and kinetic basis for the mixed agonist\/antagonist activity of estriol","volume":"11","author":"Melamed","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0145","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(97)00413-4","article-title":"The novel estrogen receptor-\u03b2 subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens","volume":"410","author":"Kuiper","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1999.00545.x","article-title":"Oestrogen receptors \u2013 an overview","volume":"246","author":"Enmark","year":"1999","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.critrevonc.2004.02.001","article-title":"Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion","volume":"51","author":"Platet","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.54.1.105","article-title":"Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists\/antagonists","volume":"54","author":"Barkhem","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.63.1.165","article-title":"Role of estrogen receptor beta in estrogen action","volume":"63","author":"Pettersson","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-009-0413-2","article-title":"Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells","volume":"120","author":"Treeck","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0180","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1210\/en.2006-0563","article-title":"Impact of estrogen receptor \u03b2 on gene networks regulated by estrogen receptor \u03b1 in Breast cancer cells","volume":"147","author":"Chang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-03-2446","article-title":"Estrogen receptor inhibits human Breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest","volume":"64","author":"Paruthiyil","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0190","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0308319100","article-title":"Estrogen receptor inhibits 17 \u2212estradiol-stimulated proliferation of the breast cancer cell line T47D","volume":"101","author":"Strom","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0195","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/GCO.0b013e3283081ae9","article-title":"Bioidentical hormone therapy: a panacea that lacks supportive evidence","volume":"20","author":"Boothby","year":"2008","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0200","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1210\/endo.142.9.8395","article-title":"ER\u03b2 inhibits proliferation and invasion of Breast cancer cells","volume":"142","author":"Lazennec","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.steroids.2012.10.014","article-title":"Estrogen receptor \u03b2 agonists affect growth and gene expression of human breast cancer cell lines","volume":"78","author":"Lattrich","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0210","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1210\/en.2003-1682","article-title":"Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) \u03b1 or ER\u03b2 in human osteosarcoma cells: distinct and common target genes for these receptors","volume":"145","author":"Stossi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0215","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1091\/mbc.e03-06-0360","article-title":"Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors \u03b1 and \u03b2","volume":"15","author":"Kian Tee","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcb.10633","article-title":"Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ER\u03b1 or ER\u03b2","volume":"90","author":"Monroe","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0225","doi-asserted-by":"crossref","first-page":"e6271","DOI":"10.1371\/journal.pone.0006271","article-title":"Drug and cell type-specific regulation of genes with different classes of estrogen receptor \u03b2-selective agonists","volume":"4","author":"Paruthiyil","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1621\/nrs.06003","article-title":"Estrogen receptor \u03b2: an overview and update","volume":"6","author":"Zhao","year":"2008","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/jme.1.01541","article-title":"Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors \u03b1 and \u03b2 by coactivators and corepressors","volume":"33","author":"Klinge","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0240","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/nar\/29.14.2905","article-title":"Estrogen receptor interaction with estrogen response elements","volume":"29","author":"Klinge","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0245","first-page":"321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0250","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by Tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0260","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0092-8674(90)90422-B","article-title":"Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex","volume":"63","author":"Gaub","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0265","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","article-title":"Differential ligand activation of estrogen receptors ER\u03b1 and ER\u03b2 at AP1 sites","volume":"277","author":"Paech","year":"1997","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0270","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M101806200","article-title":"Characterization of the physical interaction between estrogen receptor \u03b1 and JUN proteins","volume":"276","author":"Teyssier","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0275","doi-asserted-by":"crossref","first-page":"12940","DOI":"10.1016\/S0021-9258(18)99966-7","article-title":"Down-modulation of interleukin-6 gene expression by 17\u03b2-estradiol in the absence of high affinity DNA binding by the estrogen receptor","volume":"269","author":"Ray","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0280","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/MCB.15.9.4971","article-title":"Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C\/EBP beta","volume":"15","author":"Stein","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0285","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1074\/jbc.272.29.18250","article-title":"Functional interactions between the estrogen receptor and the transcription activator sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter","volume":"272","author":"de Medeiros","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0290","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/mend.11.11.9916","article-title":"Functional synergy between the transcription factor sp1 and the estrogen receptor","volume":"11","author":"Porter","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0295","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0300","doi-asserted-by":"crossref","first-page":"e0132950","DOI":"10.1371\/journal.pone.0132950","article-title":"Divide and conquer may not Be the optimal approach to retain the desirable estrogenic attributes of the cyclopia nutraceutical extract, SM6Met","volume":"10","author":"Mortimer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0305","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1210\/endo.138.4.5047","article-title":"Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor","volume":"138","author":"Szelei","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-4827(77)90089-1","article-title":"In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain","volume":"104","author":"Chen","year":"1977","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0315","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1093\/emboj\/19.17.4688","article-title":"Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1","volume":"19","author":"Flouriot","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0320","doi-asserted-by":"crossref","first-page":"30801","DOI":"10.1074\/jbc.C000484200","article-title":"Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors","volume":"275","author":"Belandia","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0325","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1128\/MCB.17.7.3733","article-title":"Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor","volume":"17","author":"Plaisance","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0330","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117943","article-title":"Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans","volume":"95","author":"Bamberger","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0345","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression. A Practical Guide to Curve Fitting","author":"Motulsky","year":"2003"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0350","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0355","doi-asserted-by":"crossref","first-page":"e79223","DOI":"10.1371\/journal.pone.0079223","article-title":"Cyclopia extracts act as ER\u03b1 antagonists and ER\u03b2 agonists, in vitro and in vivo","volume":"8","author":"Visser","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0360","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0365","doi-asserted-by":"crossref","first-page":"e9665","DOI":"10.1371\/journal.pone.0009665","article-title":"A role for Methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2\/TFF1 gene","volume":"5","author":"Chatagnon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0370","doi-asserted-by":"crossref","first-page":"e1000922","DOI":"10.1371\/journal.pgen.1000922","article-title":"Activation of estrogen-responsive genes does not require their nuclear co-localization","volume":"6","author":"Kocanova","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0375","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1183\/09031936.02.00303602","article-title":"Tumour necrosis factor- \u03b1 induced CD70 and interleukin-7R mRNA expression in BEAS-2 B cells","volume":"20","author":"Wolf","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0380","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1073\/pnas.96.8.4581","article-title":"Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0385","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/jc.2002-021353","article-title":"Sex steroid hormone receptors in human thymoma","volume":"88","author":"Ishibashi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0390","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1021\/jf063588n","article-title":"Evaluation of the phytoestrogenic activity of cyclopia genistoides (Honeybush) methanol extracts and relevant polyphenols","volume":"55","author":"Verhoog","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0395","first-page":"e51998","article-title":"The soft agar colony formation assay","volume":"92","author":"Borowicz","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0300-483X(01)00437-1","article-title":"Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens","volume":"166","author":"Gutendorf","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0405","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bcp.2006.02.002","article-title":"Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta","volume":"71","author":"Escande","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0410","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0039-128X(01)00194-5","article-title":"The ligand binding profiles of estrogen receptors \u03b1 and \u03b2 are species dependent","volume":"67","author":"Harris","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0415","doi-asserted-by":"crossref","first-page":"e003","DOI":"10.1621\/nrs.05003","article-title":"Visualizing the action of steroid hormone receptors in living cells","volume":"5","author":"Griekspoor","year":"2007","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0420","doi-asserted-by":"crossref","first-page":"19297","DOI":"10.1074\/jbc.M110.193672","article-title":"Glucocorticoid-independent repression of tumor necrosis factor (TNF) \u2212stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response","volume":"286","author":"Verhoog","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0425","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1093\/emboj\/20.24.7168","article-title":"Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor","volume":"20","author":"Reichardt","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0430","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-\u03baB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0435","first-page":"646","article-title":"Conceptual tensions between quantum mechanics and general relativity: are there experimental consequences, e.g., superconducting transducers between electromagnetic and gravitational radiation?","volume":"144","author":"Chiao","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0440","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0024-3205(02)02305-6","article-title":"The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells","volume":"72","author":"Lippert","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0445","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2014.02.006","article-title":"17\u03b2-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level","volume":"445","author":"Zhao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0450","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1289\/ehp.95103844","article-title":"The E-screen assay: a comparison of different MCF7 cell stocks","volume":"103","author":"Villalobos","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0455","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/onc.2009.139","article-title":"Anchorage-independent cell growth signature identifies tumors with metastatic potential","volume":"28","author":"Mori","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0960-0760(00)00104-7","article-title":"Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology","volume":"74","author":"Katzenellenbogen","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0465","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.maturitas.2014.01.004","article-title":"Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines","volume":"77","author":"Diller","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1012570204923","article-title":"Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells","volume":"70","author":"Pang","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0475","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.1650371","article-title":"Regulation of estrogen receptor-alpha gene expression by epidermal growth factor","volume":"165","author":"Stoica","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-0760(00)00126-6","article-title":"Differential estrogen receptor binding of estrogenic substances: a species comparison","volume":"74","author":"Matthews","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0485","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors \u03b1 and \u03b2","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2004.03.118","article-title":"Rapid yeast estrogen bioassays stably expressing human estrogen receptors \u03b1 and \u03b2, and green fluorescent protein: a comparison of different compounds with both receptor types","volume":"91","author":"Bovee","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0495","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.contraception.2017.01.001","article-title":"Endogenous thrombin potential changes during the first cycle of oral contraceptive use","volume":"95","author":"Westhoff","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: a review of the literature","volume":"15","author":"Mansour","year":"2010","journal-title":"Eur. J. Contracept. Reprod. Health Care."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(00)01640-X","article-title":"Endocrine and clinical effects of micronized estradiol administered vaginally or orally","volume":"75","author":"Tourgeman","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0510","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"M.W.S. Collaborators","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0515","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9378(97)80022-1","article-title":"Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women","volume":"176","author":"Ettinger","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0520","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0043-1354(02)00378-0","article-title":"Quantitative structure\u2013activity relationships for estrogen receptor binding affinity of phenolic chemicals","volume":"37","author":"Hu","year":"2003","journal-title":"Water Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0525","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2116\/analsci.19.1103","article-title":"Study on interactions of endocrine disruptors with estrogen receptor-beta using fluorescence polarization","volume":"19","author":"Suzuki","year":"2003","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0530","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/54.1.138","article-title":"The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands","volume":"54","author":"Blair","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0535","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/toxsci\/kfh147","article-title":"Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells","volume":"80","author":"Mueller","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0540","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.toxlet.2009.11.004","article-title":"Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications","volume":"192","author":"Dang","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0545","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0550","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1210\/en.2009-0066","article-title":"Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells","volume":"150","author":"Amiry","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0555","first-page":"13","article-title":"Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-alpha-positive breast cancer","volume":"8","author":"Casneuf","year":"2016","journal-title":"Breast Cancer Targets Ther."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0560","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1016\/S0021-9258(18)90922-1","article-title":"Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines","volume":"259","author":"Westley","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0565","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/endo.141.9.7646","article-title":"The role of CBP in estrogen receptor cross-talk with nuclear factor-\u03baB in HepG2Cells","volume":"141","author":"Harnish","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0960-0760(98)00078-8","article-title":"The oestrogen receptor regulates NF\u03baB and AP-1 activity in a cell-specific manner","volume":"67","author":"Cerillo","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0575","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0022-4731(84)90015-3","article-title":"Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo","volume":"20","author":"Katzenellenbogen","year":"1984","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0580","first-page":"1901","article-title":"Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture","volume":"37","author":"Lippman","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0585","first-page":"101","article-title":"Estriol: safety and efficacy","volume":"3","author":"Head","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0590","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/mend.12.9.0159","article-title":"Upstream stimulatory factors mediate estrogen receptor activation of the Cathepsin D promoter","volume":"12","author":"Xing","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0595","first-page":"1093","article-title":"The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity","volume":"62","author":"Azenshtein","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0600","first-page":"4681","article-title":"Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma","volume":"59","author":"Luboshits","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0605","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-5122(94)00894-D","article-title":"Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate","volume":"21","author":"Klehr-Bathmann","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0610","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9378(99)70042-6","article-title":"Serum and tissue hormone levels of vaginally and orally administered estradiol","volume":"180","author":"Tourgeman","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0615","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/gme.0b013e318148b98b","article-title":"The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status","volume":"15","author":"Gupta","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0620","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/01443619866408","article-title":"Bioavailability of oestradiol from the Alora TM (0.1 mg\/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg\/day)","volume":"18","author":"Bowen","year":"1998","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0625","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016348309154208","article-title":"Vaginal absorption of two estriol preparations: a comparative study in postmenopausal women","volume":"62","author":"Mattsson","year":"1983","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0630","series-title":"Premarin Package Insert","year":"2016"},{"key":"10.1016\/j.jsbmb.2017.07.022_bib0635","series-title":"FemHRT Package Insert","year":"2005"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:57:15Z","timestamp":1760745435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076017301875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":127,"alternative-id":["S0960076017301875"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.07.022","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-\u03b1 and -\u03b2","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}